Trial Profile
Comparison of the efficacy and safety using 0.01% vs 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Oct 2018
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Hypotrichosis
- Focus Therapeutic Use
- 20 Aug 2018 Status changed from active, no longer recruiting to completed.
- 18 Jun 2018 New trial record